Javier Jimenez
Corporate Officer/Principal chez Tatum LLC
Profil
Javier Jimenez is currently a Partner at Tatum LLC since 2008.
He is also a Partner at Tatum Expands New England Practice.
Previously, he worked as a Director at HepaLife Technologies, Inc. from 2007 to 2010.
He also served as an Independent Director at SolarWindow Technologies, Inc. from 2011 to 2012.
Additionally, he held the position of Director-Commercial Operations at GE Healthcare IVD Technologies.
Prior to that, he was the Vice President-Operations at ABIOMED, Inc. from 2004 to 2007.
Mr. Jimenez obtained an MBA from Boston University in 1996 and graduated from Universidad Politécnica de Madrid in 1991.
Postes actifs de Javier Jimenez
| Sociétés | Poste | Début |
|---|---|---|
Tatum LLC
 Tatum LLC Miscellaneous Commercial ServicesCommercial Services Tatum LLC provides executive consulting services. It provides services to the healthcare, private equity, venture capital, public, not-for-profit, manufacturing, distribution, retail, financial and business services sectors. The company was founded by John Tatum and Doug Tatum in 1993 and is located in Atlanta, GA. | Corporate Officer/Principal | 07/01/2010 |
| Tatum Expands New England Practice | Corporate Officer/Principal | - |
Anciens postes connus de Javier Jimenez
| Sociétés | Poste | Fin |
|---|---|---|
| SOLARWINDOW TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 30/09/2012 |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Directeur/Membre du Conseil | 11/05/2010 |
| ABIOMED, INC. | Directeur des opérations | 15/01/2007 |
GE Healthcare IVD Technologies
 GE Healthcare IVD Technologies Medical DistributorsDistribution Services Part of General Electric Co., GE Healthcare Technologies supplies medical equipment. | Corporate Officer/Principal | - |
Formation de Javier Jimenez
| Boston University | Masters Business Admin |
| Universidad Politécnica de Madrid | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
| Entreprise privées | 5 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Tatum LLC
Tatum LLC Miscellaneous Commercial ServicesCommercial Services Tatum LLC provides executive consulting services. It provides services to the healthcare, private equity, venture capital, public, not-for-profit, manufacturing, distribution, retail, financial and business services sectors. The company was founded by John Tatum and Doug Tatum in 1993 and is located in Atlanta, GA. | Commercial Services |
GE Healthcare IVD Technologies
GE Healthcare IVD Technologies Medical DistributorsDistribution Services Part of General Electric Co., GE Healthcare Technologies supplies medical equipment. | Distribution Services |
| Tatum Expands New England Practice |
